Your browser doesn't support javascript.
loading
PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate.
Chessa, Tamara A M; Jung, Piotr; Anwar, Arqum; Suire, Sabine; Anderson, Karen E; Barneda, David; Kielkowska, Anna; Sadiq, Barzan A; Lai, Ieng Wai; Felisbino, Sergio; Turnham, Daniel J; Pearson, Helen B; Phillips, Wayne A; Sasaki, Junko; Sasaki, Takehiko; Oxley, David; Spensberger, Dominik; Segonds-Pichon, Anne; Wilson, Michael; Walker, Simon; Okkenhaug, Hanneke; Cosulich, Sabina; Hawkins, Phillip T; Stephens, Len R.
Afiliação
  • Chessa TAM; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK. Electronic address: tamara.chessa@babraham.ac.uk.
  • Jung P; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Anwar A; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Suire S; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Anderson KE; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Barneda D; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Kielkowska A; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Sadiq BA; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Lai IW; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Felisbino S; Department of Structural and Functional Biology, São Paulo State University, Botucatu, SP CEP: 18618-689, Brazil.
  • Turnham DJ; European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK.
  • Pearson HB; European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK.
  • Phillips WA; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Sasaki J; Department of Biochemical Pathophysiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
  • Sasaki T; Department of Biochemical Pathophysiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
  • Oxley D; Mass Spectrometry Facility, Babraham Institute, Cambridge CB22 3AT, UK.
  • Spensberger D; Gene Targeting Facility, Babraham Institute, Cambridge CB22 3AT, UK.
  • Segonds-Pichon A; Bioinformatics, Babraham Institute, Cambridge CB22 3AT, UK.
  • Wilson M; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Walker S; Imaging Facility, Babraham Institute, Cambridge CB22 3AT, UK.
  • Okkenhaug H; Imaging Facility, Babraham Institute, Cambridge CB22 3AT, UK.
  • Cosulich S; Projects Group, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Hawkins PT; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK.
  • Stephens LR; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK. Electronic address: len.stephens@babraham.ac.uk.
Mol Cell ; 83(16): 2991-3009.e13, 2023 08 17.
Article em En | MEDLINE | ID: mdl-37567175

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / PTEN Fosfo-Hidrolase Limite: Animals / Humans / Male Idioma: En Revista: Mol Cell Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / PTEN Fosfo-Hidrolase Limite: Animals / Humans / Male Idioma: En Revista: Mol Cell Ano de publicação: 2023 Tipo de documento: Article